|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/145 | |||
| A61K 39/385 | |||
| C07H 3/00 | |||
| C12N 7/00 | |||
| A61K 39/095 | |||
| A61K 39/102 |
| (11) | Patento numeris | 2283857 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10177832.2 |
| Europos patento paraiškos padavimo data | 2006-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-02-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0513071 | 2005-06-27 | GB | |
| 0513069 | 2005-06-27 | GB | |
| 0515556 | 2005-07-28 | GB | |
| 0524204 | 2005-11-28 | GB | |
| 0526040 | 2005-12-21 | GB | |
| 0526041 | 2005-12-21 | GB |
| (72) |
Biemans, Ralph, BE
Boutriau, Dominique, BE
Capiau, Carine, BE
Denoel, Philippe, BE
Duvivier, Pierre, BE
Poolman, Jan, BE
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | Vaccine composition comprising conjugated native N. Meningitidis capsular polysaccharides |
| Vaccine composition comprising conjugated native N. Meningitidis capsular polysaccharides |